Evigrade
Major

Digoxin × Verapamil

Cardiac glycosides (digitalis)×Non-dihydropyridine calcium channel blocker

Mechanism

Verapamil inhibits P-glycoprotein, which clears digoxin via kidney and intestine. Digoxin plasma concentration rises 50–75%. Digoxin has a narrow therapeutic index (target 0.5–0.9 ng/mL, toxic above 2). Verapamil also amplifies digoxin's bradycardia and AV block.

Symptoms

Nausea, vomiting, visual disturbances (yellow halos), bradycardia below 50, AV blocks, ventricular arrhythmias.

Management

When starting verapamil, reduce digoxin by 30–50% and check level on days 5–7. Alternative calcium channel blocker: amlodipine, which does not inhibit P-glycoprotein. Avoid the combination in the elderly.

Check the full regimen, not just this pair

Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.

Open checker

Sources

All interactions